IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.965
EU - Europa 4.936
AS - Asia 3.172
SA - Sud America 210
AF - Africa 30
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 14.341
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.903
SG - Singapore 1.121
CN - Cina 1.062
UA - Ucraina 907
IE - Irlanda 883
SE - Svezia 756
IT - Italia 626
TR - Turchia 621
GB - Regno Unito 524
DE - Germania 355
FR - Francia 353
FI - Finlandia 198
IN - India 194
BR - Brasile 185
RU - Federazione Russa 176
CA - Canada 48
HK - Hong Kong 46
BE - Belgio 37
TW - Taiwan 25
AT - Austria 21
VN - Vietnam 20
AU - Australia 15
CZ - Repubblica Ceca 14
NL - Olanda 14
KR - Corea 13
PL - Polonia 13
GR - Grecia 12
EU - Europa 11
IR - Iran 11
AR - Argentina 9
EC - Ecuador 8
JP - Giappone 8
RO - Romania 8
BD - Bangladesh 7
IL - Israele 7
MX - Messico 7
ZA - Sudafrica 7
ES - Italia 6
ID - Indonesia 6
KE - Kenya 5
TH - Thailandia 5
DZ - Algeria 4
IQ - Iraq 4
LT - Lituania 4
MA - Marocco 4
NO - Norvegia 4
TN - Tunisia 4
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
JO - Giordania 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
CI - Costa d'Avorio 2
CL - Cile 2
CU - Cuba 2
HR - Croazia 2
JM - Giamaica 2
LK - Sri Lanka 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 14.341
Salva come PNG Salva come JPEG
Città #
Chandler 1.099
Jacksonville 1.040
Dublin 868
Singapore 756
Princeton 437
Southend 385
Izmir 325
Nanjing 290
Dearborn 247
Wilmington 222
Ashburn 171
Cambridge 170
Santa Clara 166
Beijing 159
The Dalles 149
Altamura 138
Ann Arbor 131
Chieti 126
Nanchang 98
Boardman 81
Woodbridge 80
Hebei 65
Los Angeles 56
Shenyang 54
Kunming 48
Jiaxing 43
Tianjin 42
Hong Kong 41
Helsinki 40
New York 37
Washington 33
Grevenbroich 32
Brussels 31
Munich 30
Pescara 30
Changsha 28
Hangzhou 28
San Mateo 28
Houston 26
Norwalk 25
Falls Church 24
Jinan 21
Guangzhou 20
Leawood 20
Seattle 20
São Paulo 19
Augusta 18
Nuremberg 18
Toronto 18
Orange 16
Dong Ket 14
Milan 14
Ningbo 14
Taipei 14
Hefei 13
Auburn Hills 12
Kocaeli 12
Lanzhou 12
Moscow 12
Teramo 11
Hanover 10
Kraków 10
Vienna 10
Zhengzhou 10
Bellante 8
Brno 8
Changchun 8
Edinburgh 8
Rio de Janeiro 8
Rome 8
Shanghai 8
Sydney 8
Cologno Monzese 7
Monmouth Junction 7
Montenero Di Bisaccia 7
San Giovanni 7
Sant'onofrio 7
Taizhou 7
Ardabil 6
Pianella 6
Romola 6
Silvi 6
Tappahannock 6
West Jordan 6
Bangkok 5
Buffalo 5
Dhaka 5
Hanoi 5
Montesilvano Marina 5
Nairobi 5
Olomouc 5
Paris 5
Pune 5
Rochester 5
Altino 4
Amsterdam 4
Baghdad 4
Brasília 4
Fuzhou 4
Lappeenranta 4
Totale 8.433
Salva come PNG Salva come JPEG
Nome #
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 229
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 207
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 121
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 119
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 118
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 117
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 115
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 110
Apixaban for extended treatment of venous thromboembolism 107
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 106
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 106
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 104
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 102
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 101
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 99
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 99
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 99
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 97
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 97
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 96
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 95
Oral rivaroxaban for symptomatic venous thromboembolism 94
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 93
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 92
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 91
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 91
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 91
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 90
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 90
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 90
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 90
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 89
[Physiopathological bases of the medical treatment of portal hypertension]. 89
Oral apixaban for the treatment of acute venous thromboembolism 89
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 88
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 88
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 88
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 88
Circulating leptin is associated with oxidized LDL in postmenopausal women. 87
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 87
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 87
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 86
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 86
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 84
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 84
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 84
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 84
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 84
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 83
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 83
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 83
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 83
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 83
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 83
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 83
The hematocrit and platelet target in polycytemia vera 82
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 82
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 82
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 82
Determinants of platelet activation in Alzheimer's disease 82
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 81
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 81
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 81
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 81
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 81
Iron status and oxidative stress in the aged rabbit heart 81
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 81
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 80
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 80
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 80
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 80
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 79
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 79
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 79
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 79
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 78
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 78
Non-O blood group and outcomes of in vitro fertilization 78
Systemic oxidative stress status in patients with ischemic heart disease 77
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 77
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 77
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 76
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 76
Effects of body composition on the procoagulant imbalance in obese patients 76
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 75
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 75
Effect of high fat-, cholesterol-enriched diet on the antioxidant defence mechanisms in the rabbit heart 75
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 75
Rivaroxaban for cancer-associated cardiac thrombosis 75
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 74
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 73
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 73
Vascular non-protein thiols: prooxidants or antioxidants in atherogenesis? 73
Time course of aortic antioxidant defense mechanisms in rabbit experimental atherosclerosis 73
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 73
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 73
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 72
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 72
EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE 6-METHOXY-2-NAPHTHYL ACETIC ACID ON HUMAN BLOOD PROSTAGLANDIN H SYNTHASES. 72
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 72
Totale 8.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020250 0 0 0 0 0 0 0 0 0 0 228 22
2020/20211.274 171 15 222 26 104 268 15 20 97 163 79 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20252.741 241 625 537 56 65 138 90 175 401 223 190 0
Totale 14.910